Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Povidone-Iodine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pleural Effusion, Malignant 2 Wound Infection 1 Urinary Tract Infections 1 Stomatitis 1 Skin Neoplasms 1 Sepsis 1 Prostatic Neoplasms 1 Pneumothorax 1 Pleural Effusion 1 Head and Neck Neoplasms 1 Fever 1 Esophageal Neoplasms 1 Breast Neoplasms 1

Interventions

Cisplatin 147 Fluorouracil 124 Paclitaxel 116 Radiotherapy 113 Oxaliplatin 81 Docetaxel 66 Carboplatin 61 Irinotecan 56 Leucovorin 54 pembrolizumab 53 Capecitabine 52 Radiation 43 Esophagectomy 40 Surgical Procedures, Operative 39 Drug Therapy 31 Cetuximab 24 Neoadjuvant Therapy 23 Nivolumab 22 Bevacizumab 21 Trastuzumab 19 camrelizumab 18 S 1 (combination) 17 Magnetic Resonance Spectroscopy 17 Chemoradiotherapy 17 Albumin-Bound Paclitaxel 16 Epirubicin 14 Blood Specimen Collection 14 tislelizumab 13 Taxes 13 Gemcitabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02676791 2022-07-14

LOCARE

Technische Universität Dresden

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡